Home / Pharmaceutical / Mauritius Pharmaceuticals Report

Mauritius Pharmaceuticals Report

Published: Feb 2015 | No Of Pages: 53 | Published By: Espicom

Product Synopsis

The Mauritius Pharmaceuticals Report features Business Monitor International (BMI)'s forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.
 
BMI's Mauritius Pharmaceuticals Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Mauritius pharmaceutical and healthcare industry.
 
Key Benefits
  • Benchmark BMI's pharmaceutical and healthcare market forecasts for Mauritius, to test other views a key input for successful budgeting and strategic business planning in the Mauritian pharmaceutical and healthcare market.
  • Target business opportunities and risks in the Mauritian pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Mauritius.
  • Assess the activities, strategy and market position of your competitors via our Company Profiles (inc. SWOTs, KPIs and latest activity) and Competitive Landscape Tables.
Coverage
 
BMI Industry View
 
An at-a-glance perspective on the latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The pharmaceuticals and healthcare SWOT outlines strategic factors that affect the basic assumptions underpinning BMI’s forecast analysis, and taken together with BMI’s political, economic and business environment SWOTs, it gives a complete overview of market climate.
 
BMI Industry Forecast Scenario
 
Industry forecasts to end-2019 for all key indicators, supported by explicit assumptions, plus analysis of key downside risks to the main forecasts:
  • Healthcare: Total healthcare expenditure (USDbn), healthcare expenditure (% of GDP), healthcare expenditure per capita (USD), hospital beds, doctors, and birth & mortality rates (all per ‘000 population).
  • Pharmaceutical Market: Drug expenditure in USDbn, % of GDP and per capita (USD).
  • Patented Drug Market: Prescription drug sales (USDbn & % of total sales).
  • Generic Drug Market: Generic product sales (USDbn), generic sales (% of total sales).
  • OTC Drug Market: OTC sales (USDbn & % of total sales).
Macroeconomic Forecasts: Nominal and real GDP, % real GDP growth, % private consumption growth, % industrial output growth, % consumer price index, % GDP price deflator, exports, imports, trade balance, current account balance, foreign direct investment, exchange rate against USD, government expenditure and external debt.
 
BMI’s Pharmaceuticals and Healthcare Risk Reward Index
 
BMI’s Risk Reward Index provides investors (both national and multinational) looking for opportunities in the region with a clear country-comparative assessment of the market’s risks and potential rewards. Each of the country markets are scored using a sophisticated model that includes more than 40 industry, economic and demographic data points to provide indices of highest to lowest appeal to investors, with each position explained.
 
Market Summary
 
A snapshot of key market characteristics, including total size of the pharmaceuticals and healthcare segments, growth drivers, leading therapeutic areas and the competitive landscape
 
Industry Developments
 
A focus on government healthcare reforms, epidemiological trends, mergers and acquisitions, product launches, market entries, FDI activity, R&D, biotechnology, clinical trials and supply chain issues.
 
Regulatory Regime
 
Details of the industry regulatory framework and key legislation covering the licensing of new products/services, pricing and reimbursements, intellectual property, taxation and advertising, as well as analysis of the overall regulatory burden.
 
Competitive Landscape
 
The competitive landscape section provides comparative company analyses and index by USD sales and % share of total sales – for the total pharmaceutical sector, as well as the OTC, generics and distribution sub-sectors.
 
Company Profiles*
 
Examines the competitive positioning and short- to medium-term business strategies of key industry players. Strategy is examined within the context of BMI’s industry forecasts, our macroeconomic views and our understanding of the wider competitive landscape to generate Company SWOT analyses. The latest financial and operating statistics and key company developments are also incorporated within the company profiles, enabling a full evaluation of recent company performance and future growth prospects.
BMI Industry View7
SWOT8
Political9
Economic10
Industry Forecast11
Pharmaceutical Market Forecast11
 
Table: Pharmaceutical Sales, Historical Data And Forecasts (Mauritius 2010-2018)12
 
Healthcare Market Forecast14
 
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Mauritius 2010-2018)15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Mauritius 2010-2018)16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Mauritius 2010-2018)16
 
Macroeconomic Forecasts17
Economic Analysis17
 
Table: Mauritius - Economic Activity20
 
Industry Risk Reward Ratings21
Middle East & Africa Risk/Reward Ratings21
Mauritius Risk/Reward Ratings28
Market Overview30
Industry Trends And Developments31
Healthcare Provision32
Regulatory Development33
Pricing33
Reimbursement37
Intellectual Property Issues38
Competitive Landscape39
Demographic Forecast41
 
Table: Mauritius' Population By Age Group, 1990-2020 ('000)42
Table: Mauritius' Population By Age Group, 1990-2020 (% of total)43
Table: Mauritius' Key Population Ratios, 1990-202044
Table: Mauritius' Rural And Urban Population, 1990-202044
 
Glossary45
Methodology47
Pharmaceutical Expenditure Forecast Model47
Healthcare Expenditure Forecast Model47
Notes On Methodology48
Risk/Reward Ratings Methodology49
Ratings Overview50
 
Table: Pharmaceutical Risk/Reward Ratings Indicators50
Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +